Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
PAVM - PAVmed Inc - Stock Price Chart
TickerPAVM [NASD]
CompanyPAVmed Inc
CountryUSA
IndustryMedical Devices
Market Cap8.05MEPS (ttm)-9.04
P/E-EPS this Y28.97%
Forward P/E-EPS next Y43.44%
PEG-EPS past 5Y6.21%
P/S2.67EPS next 5Y-
P/B-EPS Q/Q5.78%
Dividend-Sales Q/Q126.46%
Insider Own12.19%Inst Own14.16%
Insider Trans0.00%Inst Trans76.73%
Short Float3.30%EarningsMay 14/b
Analyst Recom1.50Target Price9.75
Avg Volume62.88K52W Range0.92 - 7.76
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. The company's products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. PAVmed was founded on June 26, 2014 and is headquartered in New York, NY.
SEEL - Seelos Therapeutics Inc - Stock Price Chart
TickerSEEL [NASD]
CompanySeelos Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.14MEPS (ttm)-42.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y62.30%
P/S1.09EPS next 5Y-
P/B-EPS Q/Q94.28%
Dividend-Sales Q/Q-28.34%
Insider Own5.83%Inst Own11.48%
Insider Trans0.00%Inst Trans-84.52%
Short Float10.22%Earnings-
Analyst Recom1.00Target Price32.00
Avg Volume91.42K52W Range0.80 - 398.40
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mehra RajSee RemarksDec 01 '23Buy1.3275,75799,999185,142Dec 01 04:16 PM
Golembiewski Michael JosephChief Financial OfficerNov 30 '23Buy1.2183,000100,22286,450Dec 01 04:16 PM
INVZ - Innoviz Technologies Ltd - Stock Price Chart
TickerINVZ [NASD]
CompanyInnoviz Technologies Ltd
CountryIsrael
IndustryAuto Parts
Market Cap143.29MEPS (ttm)-0.77
P/E-EPS this Y22.86%
Forward P/E-EPS next Y16.98%
PEG-EPS past 5Y24.35%
P/S5.32EPS next 5Y-
P/B-EPS Q/Q28.72%
Dividend-Sales Q/Q598.71%
Insider Own4.36%Inst Own39.93%
Insider Trans0.00%Inst Trans7.95%
Short Float7.76%EarningsMay 08/b
Analyst Recom1.40Target Price4.30
Avg Volume1.80M52W Range0.90 - 4.39
May-28-24 08:00AM Innoviz Collaborating with Ecomotion Community to Host the Annual Assembly (PR Newswire)
May-08-24 11:57AM INVZ Stock Earnings: Innoviz Technologies Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) +16.07%
07:00AM Innoviz Reports First-Quarter 2024 Results, Exceeds Revenue Guidance for Second Consecutive Quarter and Expands Key Partner and Customer Relationships (PR Newswire)
05:45AM Shareholders of Innoviz Technologies Ltd. Should Contact Levi & Korsinsky Before May 14, 2024 to Discuss Your Rights - INVZ (PR Newswire)
Apr-18-24 09:00AM Innoviz Reaches a Key Milestone with Successful Winter Test of InnovizTwo LiDAR and AI-Powered Perception Software, Showcasing Significant Progress and New Opportunities (PR Newswire)
Apr-17-24 09:00AM Innoviz Sets First Quarter 2024 Conference Call for Wednesday, May 8 at 9:00 a.m. ET (PR Newswire)
Apr-15-24 05:45AM Innoviz Technologies Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - INVZ (PR Newswire)
Mar-31-24 02:19AM INVZ STOCKHOLDERS: Contact Robbins LLP for Information About Your Rights and Remedies Against Innoviz Technologies Ltd. (Business Wire)
Mar-21-24 12:45PM Innoviz Technologies Ltd. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before May 14, 2024 to Discuss Your Rights INVZ (GlobeNewswire)
Mar-20-24 05:45AM Shareholders of Innoviz Technologies Ltd. Should Contact Levi & Korsinsky Before May 14, 2024 to Discuss Your Rights - INVZ (PR Newswire)
Innoviz Technologies Ltd. designs and manufactures solid-state LiDAR sensors and perception software that enable the mass production of autonomous vehicles. It offers InnovizOne, an automotive-grade, mass-producible LiDAR sensor, InnovizTwo, next generation high-performance automotive-grade LiDAR sensor, and Innoviz's perception software, designed to complement its hardware offerings with advanced AI and machine learning-based classification, detection and tracking features. The firm is backed by top-tier strategic partners and investors, including SoftBank Ventures Asia, Samsung, Magna International, Aptiv, Magma Venture Partners, Vertex Ventures, 360 Capital Partners, Harel Insurance Investments and Financial Services, Phoenix Insurance Company and others. The company was founded by Omer David Keilaf, Oren Buskila, and Oren Rosenzweig on January 18, 2016 and is headquartered in Rosh Haayin, Israel.
ZPTA - Zapata Computing Holdings Inc. - Stock Price Chart
TickerZPTA [NASD]
CompanyZapata Computing Holdings Inc.
CountryUSA
IndustrySoftware - Infrastructure
Market Cap18.94MEPS (ttm)-4.21
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S15.53EPS next 5Y-
P/B-EPS Q/Q-44077.42%
Dividend-Sales Q/Q-
Insider Own34.63%Inst Own5.09%
Insider Trans0.00%Inst Trans6.23%
Short Float1.85%Earnings-
Analyst Recom-Target Price-
Avg Volume1.39M52W Range0.63 - 18.50
Zapata Computing Holdings, Inc. operates as a generative AI company. It provides data science and engineering techniques for solutions on an industrial scale. The company was founded by Christopher Savoie, Alan Aspuru-Guzik, Yudong Cao, Jonathan Olson, Peter Johnson, and Jonathan Romero-Fontalvo in 2017 and is headquartered in Boston, MA.
PXDT - Pixie Dust Technologies Inc ADR - Stock Price Chart
TickerPXDT [NASD]
CompanyPixie Dust Technologies Inc ADR
CountryJapan
IndustryConsumer Electronics
Market Cap21.32MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.46EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.52%
Insider Trans-Inst Trans-
Short Float-EarningsFeb 13/a
Analyst Recom1.00Target Price5.24
Avg Volume12.24K52W Range1.53 - 10.51
Pixie Dust Technologies, Inc. engages in providing consumer personal care products and spatial materials through the utilization of mechanobiology and metamaterials. It operates through Personal Care and Diversity, and Workspace and Digital Transformation divisions. The Personal Care and Diversity division develops technologies to enhance personal care and quality of life. The Workspace and Digital Transformation division develops technologies for sensing and controlling space. The company was founded by Yoichi Ochiai, Takayuki Hoshi and Taiichiro Murakami on May 10, 2017 and is headquartered in Tokyo, Japan.
TCRT - Alaunos Therapeutics Inc - Stock Price Chart
TickerTCRT [NASD]
CompanyAlaunos Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap9.96MEPS (ttm)-1.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y21.41%
P/S995.98EPS next 5Y-
P/B2.08EPS Q/Q83.30%
Dividend-Sales Q/Q-
Insider Own14.04%Inst Own14.67%
Insider Trans0.00%Inst Trans23.51%
Short Float10.33%Earnings-
Analyst Recom3.00Target Price112.50
Avg Volume43.39K52W Range0.66 - 7.95
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boyle Kevin S. Sr.Chief Executive OfficerSep 01 '23Sale0.1468,0149,542798,236Sep 05 05:34 PM
SONN - Sonnet BioTherapeutics Holdings Inc - Stock Price Chart
TickerSONN [NASD]
CompanySonnet BioTherapeutics Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap3.23MEPS (ttm)-5.28
P/E-EPS this Y89.27%
Forward P/E-EPS next Y-29.45%
PEG-EPS past 5Y74.20%
P/S35.94EPS next 5Y-
P/B1.06EPS Q/Q101.05%
Dividend-Sales Q/Q-100.00%
Insider Own9.14%Inst Own2.04%
Insider Trans0.00%Inst Trans7.98%
Short Float12.17%EarningsMay 14/a
Analyst Recom1.00Target Price11.50
Avg Volume26.47K52W Range1.08 - 19.25
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among other important functions, serve as potent immunomodulatory agents. The company was founded by Pankaj Mohan and John K. Cini in 2011 and is headquartered in Princeton, NJ.
FLFV - Feutune Light Acquisition Corp - Stock Price Chart
TickerFLFV [NASD]
CompanyFeutune Light Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap47.29MEPS (ttm)0.06
P/E136.85EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.19EPS Q/Q-105.23%
Dividend-Sales Q/Q-
Insider Own58.05%Inst Own51.47%
Insider Trans0.00%Inst Trans-
Short Float0.92%Earnings-
Analyst Recom-Target Price-
Avg Volume76.42K52W Range7.57 - 12.12
Jun-18-24 01:30AM Feutune Light Acquisition Corporation Announces Approval of Business Combination by Stockholders (GlobeNewswire)
Jun-17-24 07:40AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -21.14%
Jun-11-24 01:00AM Feutune Light Acquisition Corporation Announces that It Will Adjourn the Special Meeting of Stockholders to Approve Business Combination with Thunder Power Holdings Limited to June 17, 2024 (GlobeNewswire) +7.52%
May-22-24 07:50PM Feutune Light Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination and Issuances of Promissory Notes (GlobeNewswire)
Apr-18-24 05:15PM Feutune Light Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Mar-19-24 10:21PM Feutune Light Acquisition Corporation Announces Stockholder Approval for Extending Business Combination Deadline and Merger Agreement Amendment with Thunder Power Holdings Limited (GlobeNewswire)
Feb-21-24 04:30PM Feutune Light Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Jan-19-24 04:34PM Feutune Light Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Dec-21-23 08:30AM Feutune Light Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Nov-21-23 01:00PM Feutune Light Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Feutune Light Acquisition Corp. is a blank check company engaged in effecting a merger, share exchange, asset acquisition, share purchase, reorganization, and business combination. The company was founded on January 19, 2022 and is headquartered in Metuchen, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davidov MichaelFormer DirectorOct 06 '23Sale0.0110,00010210,000Oct 06 10:27 AM
RDZN - Roadzen Inc - Stock Price Chart
TickerRDZN [NASD]
CompanyRoadzen Inc
CountryUSA
IndustrySoftware - Application
Market Cap150.57MEPS (ttm)0.05
P/E40.67EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1672.89%
Dividend-Sales Q/Q-
Insider Own75.03%Inst Own7.16%
Insider Trans0.00%Inst Trans1.33%
Short Float0.17%EarningsMay 29
Analyst Recom1.00Target Price10.00
Avg Volume26.10K52W Range2.23 - 17.00
Roadzen, Inc. operates as an insurance technology company. It offers auto insurance services through artificial intelligence technology. The company was founded by Rohan Malhotra on May 7, 2015 and is headquartered in Burlingame, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHAH AJAYDirectorDec 13 '23Buy3.1010,00031,000487,399Dec 15 11:12 AM
SHAH AJAYDirectorDec 12 '23Buy3.085,00015,400477,399Dec 15 11:12 AM
VedBrat SupurnaDirectorDec 11 '23Buy2.912,0005,8208,250Dec 15 10:00 AM
VedBrat SupurnaDirectorDec 08 '23Buy3.113,1009,6416,250Dec 15 10:00 AM
VedBrat SupurnaDirectorDec 07 '23Buy3.203,15010,0803,150Dec 15 10:00 AM
AZTR - Azitra Inc - Stock Price Chart
TickerAZTR [AMEX]
CompanyAzitra Inc
CountryUSA
IndustryBiotechnology
Market Cap4.10MEPS (ttm)-0.93
P/E-EPS this Y77.60%
Forward P/E-EPS next Y4.88%
PEG-EPS past 5Y-
P/S7.19EPS next 5Y-
P/B0.95EPS Q/Q44.58%
Dividend-Sales Q/Q-100.00%
Insider Own44.22%Inst Own5.20%
Insider Trans3.24%Inst Trans-
Short Float0.78%EarningsMay 09/a
Analyst Recom1.00Target Price2.00
Avg Volume1.70M52W Range0.14 - 5.18
Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Staskey NormChief Financial OfficerMar 29 '24Buy0.2147,60010,03451,100Apr 01 09:51 PM
Salva Francisco D.President and CEOFeb 13 '24Buy0.30333,30099,990338,300Feb 15 08:38 PM
Whitfill TravisChief Operating OfficerFeb 13 '24Buy0.3015,0004,500334,500Feb 15 08:42 PM
Staskey NormChief Financial OfficerFeb 13 '24Buy0.303,3009903,500Feb 15 08:39 PM
1234567891020